Softbank's $9 billion net loss last year has a lot to do with Uber and WeWork
- SoftBank Group reported a record $8.9 billion net loss for the last financial year ended March 2020.
- The Softbank Vision Fund had $75 billion invested in 88 startups but they were worth 7% less in value at the end of March.
- The operating loss, before adding interest and tax, was $13 billion compared to a profit of $19 billion a year earlier.
The Softbank Vision Fund had $75 billion invested in 88 startups but they were worth 7% less in value at the end of March. The operating loss, before adding interest and tax, was $13 billion at the end of March, compared to a profit of nearly 2 trillion yen ( about $19 billion) a year earlier.
|Softbank Group||FY20 loss|
|Net loss||$8.9 billion|
|Operating loss||$13 billion|
|Loss from Softbank Vision Fund||$17.7 billlion|
This is the first time in 15 years Softbank posted a loss because of ‘the deteriorating performance of its tech bets’. WeWork, the US-based realty company went under last year as a cloud of dirt exploded from under the carpet at a time when the company was looking to file for an IPO. As its financials were questioned, the value of WeWork dropped from $47 billion to $8 billion.
Another one of its biggest tech bets – Uber has been on a downtrend since its listing. The market value of one of the most hallowed startups of all time is down 21.9% since its listing on Nasdaq in May 2019.
SoftBank announced its largest ever share buyback to prop up their value in March. Son has already pledged two of every five shares in Softbank as collateral for loans.
Jack Ma leaves the board
Till date, Son’s most paid-off bet is considered to be the Chinese giant Alibaba. And now, the billionaire founder of Alibaba, Jack Ma, is set to leave the SoftBank board to focus on philanthropy. This will be the most high-profile exit from the Japanese investment group.
Amazon and Walmart's newest competitor in Indian e-commerce is a yoga guru turned entrepreneur with a mass appeal
Startups who need money during COVID-19— don’t sell your stake now, warn experts
- K'taka health minister defends Covaxin, says it's safe
- Expert panel recommends Phase 1 trial of nasal Covid-19 vaccine (IANS Exclusive, Lead)
- Bombay High Court permits Sebamed ads targeting Dove with no changes and asks to put an end on Lux’s comparison with Rin
- Vaccine hesitancy among healthcare workers must end: Govt
- Software firm Magenic is the third acquisition of Cognizant in January this year